BRPI0812253A2 - Derivados de prolinamida-tetrazol como antagonistas do receptor nk-3 - Google Patents

Derivados de prolinamida-tetrazol como antagonistas do receptor nk-3

Info

Publication number
BRPI0812253A2
BRPI0812253A2 BRPI0812253-9A2A BRPI0812253A BRPI0812253A2 BR PI0812253 A2 BRPI0812253 A2 BR PI0812253A2 BR PI0812253 A BRPI0812253 A BR PI0812253A BR PI0812253 A2 BRPI0812253 A2 BR PI0812253A2
Authority
BR
Brazil
Prior art keywords
receptor antagonists
prolinamide
tetrazol
derivatives
tetrazol derivatives
Prior art date
Application number
BRPI0812253-9A2A
Other languages
English (en)
Inventor
Bo Han
Henner Knust
Matthias Nettekoven
Hasane Ratni
Xihan Wu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0812253A2 publication Critical patent/BRPI0812253A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0812253-9A2A 2007-06-07 2008-05-29 Derivados de prolinamida-tetrazol como antagonistas do receptor nk-3 BRPI0812253A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109783 2007-06-07
PCT/EP2008/056587 WO2008148688A1 (en) 2007-06-07 2008-05-29 Prolinamide-tetrazole derivatives as nk3 receptor antagonists

Publications (1)

Publication Number Publication Date
BRPI0812253A2 true BRPI0812253A2 (pt) 2014-12-23

Family

ID=39768738

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812253-9A2A BRPI0812253A2 (pt) 2007-06-07 2008-05-29 Derivados de prolinamida-tetrazol como antagonistas do receptor nk-3

Country Status (14)

Country Link
US (1) US7501422B2 (pt)
EP (1) EP2155729B1 (pt)
JP (1) JP2010529068A (pt)
KR (1) KR101163294B1 (pt)
CN (1) CN101679385A (pt)
AT (1) ATE498622T1 (pt)
AU (1) AU2008258664B2 (pt)
BR (1) BRPI0812253A2 (pt)
CA (1) CA2690292A1 (pt)
DE (1) DE602008005014D1 (pt)
ES (1) ES2359598T3 (pt)
IL (1) IL202282A0 (pt)
MX (1) MX2009013116A (pt)
WO (1) WO2008148688A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023042914A1 (en) * 2021-09-17 2023-03-23 Otsuka Pharmaceutical Co., Ltd. Pyrrolidine compounds as histone deacetylase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040034019A1 (en) 2002-08-08 2004-02-19 Ronald Tomlinson Piperazine and piperidine derivatives

Also Published As

Publication number Publication date
CA2690292A1 (en) 2008-12-11
US20080306089A1 (en) 2008-12-11
KR101163294B1 (ko) 2012-07-05
EP2155729A1 (en) 2010-02-24
EP2155729B1 (en) 2011-02-16
MX2009013116A (es) 2010-01-15
JP2010529068A (ja) 2010-08-26
AU2008258664A8 (en) 2010-01-14
ES2359598T3 (es) 2011-05-25
ATE498622T1 (de) 2011-03-15
DE602008005014D1 (de) 2011-03-31
IL202282A0 (en) 2010-06-16
WO2008148688A1 (en) 2008-12-11
CN101679385A (zh) 2010-03-24
AU2008258664B2 (en) 2012-07-05
US7501422B2 (en) 2009-03-10
AU2008258664A1 (en) 2008-12-11
KR20100020026A (ko) 2010-02-19

Similar Documents

Publication Publication Date Title
BRPI0812447A2 (pt) Derivados de prolinamida como antagonistas de nk3
PH12013500247A1 (en) Heterocyclic compound and use thereof
MX374512B (es) Compuestos de 1,3-oxazin-2-amina fusionados con ciclopropilo perfluorado como inhibidores de beta-secretasa y métodos de uso.
MX366855B (es) Compuestos perfluorados de 5,6-dihidro-4h-1,3-oxazin-2-amina como inhibidores de beta-secretasa y metodos de uso.
MA32898B1 (fr) Modulateurs allosteriques positifs du recepteur m1 d'arylmethylbenzoquinazolinone
PE20121640A1 (es) Derivados de pirazina como inhibidores de bace
ATE438632T1 (de) Aryl-4-ethinylisoxazolderivate
IL186777A0 (en) (3,4-dihydro-quinazolin-2-yl) - (2-aryloxy-ethyl) - amines having an activity on the 5 - ht receptor
MX2010002899A (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3.
MX2011008850A (es) Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3).
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
MY168937A (en) Ethynyl derivatives as modulators of mglur5 receptor activity
BRPI0916657A2 (pt) pirrolidin-3-ilmetil-amina como antagonistas de orexina
MX2012001799A (es) Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3).
PH12015502692A1 (en) Ethynyl derivatives as metabotropic glutamate receptor antagonists
BR112012014576A2 (pt) derivados de pirrolidina como antagonistas do receptor nk-3
MX2011008178A (es) Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3).
ATE546455T1 (de) Spiropiperidinderivate als nk3-antagonisten
UA114008C2 (xx) Похідні етинілу як модулятори активності рецептора mglur5
BRPI0812253A2 (pt) Derivados de prolinamida-tetrazol como antagonistas do receptor nk-3
BRPI0816971A2 (pt) Derivados de piperidina como antagonistas de receptor nk3
BRPI0712608A8 (pt) oxindoldioxanos, síntese dos mesmos e intermediários dos mesmos
BRPI0606730A2 (pt) derivados de fenil metanona 2,5-di-substituìdos como inibidores do transportador de glicina 1 (glyt-1) para o tratamento de distúbios neurológicos e neuropsiquiátricos
MX2009013186A (es) Derivados de piperazina y [1,4]diazepan como antagonistas de neurocinina.
TN2013000034A1 (en) Heterocyclic compound and use thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.